Clinical Trials Browser

INDUSTRY × Topotecan × Genitourinary × Clear all

NCT00158886 2017-11-14

Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer

Phase 1 Terminated

Carcinoma, Renal Cell